Key facts
- It has raised $3.5M; the latest was Early Stage VC ($3.5M) in Jul 2025.
- Notable investors include Vento, Basis (VC), Nucleus Capital, Nument Capital, Onstage (London) — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for ScienceMachine
- ·The full record, as it builds
Funding rounds
No funding rounds for ScienceMachine are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ScienceMachine
Developer of a biotechnology research system intended to accelerate biomedical discovery. The company uses artificial intelligence technology intended to analyze complex biological data in minutes, enabling scientists in biotech and pharma to create a tailored data analysis pipeline to get to the answer by leveraging neuro-symbolic AI.
- Sector
- Information Technology
- HQ
- New Castle, DE, United States
- Founded
- 2024
- Employees
- 4
- Website
- sciencemachine.ai/
- Ownership
- Privately Held (backing)
ScienceMachine doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ScienceMachine shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ScienceMachine in its N-PORT filings yet. We sweep new filings monthly.